skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A qualitative assessment of factors influencing acceptance of a new rotavirus vaccine among health care providers and consumers

Journal Article · · BMC Pediatric
OSTI ID:920040

In 2006, a new rotavirus vaccine (RotaTeq) was licensed in the US and recommended for routine immunization of all US infants. Because a previously licensed vaccine (Rotashield) was withdrawn from the US for safety concerns, identifying barriers to uptake of RotaTeq will help develop strategies to broaden vaccine coverage. Our qualitative assessment provides complementary data to recent quantitative surveys and suggests that physicians and parents are likely to adopt the newly licensed rotavirus vaccine. Increasing parental awareness of the rotavirus disease burden and providing physicians with timely post-marketing surveillance data will be integral to a successful vaccination program.

Research Organization:
Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN
Sponsoring Organization:
USDOE
DOE Contract Number:
DE-AC05-06OR23100
OSTI ID:
920040
Report Number(s):
ORISE-07-PTT-1309; TRN: US200822%%672
Journal Information:
BMC Pediatric, Vol. 7, Issue 32
Country of Publication:
United States
Language:
English